Brant Delafontaine

3PUBLICATIONS
57CO-AUTHORS
Gene and molecular therapyMolecular targetsManufacturing processes and technologies (excl. textiles)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 28, 2025
A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors.

Oliver Bechter, Carmen Loquai, Stephane Champiat

|Nov 09, 2022
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer.

Jonathan Chou, Emily A Egusa, Sinan Wang

|Jan 14, 2019
Switchability of Gabapentin Formulations: A Randomized Trial to Assess Bioequivalence Between Neurontin and Gabasandoz on the Individual Subject Level.

Griet Van Lancker, Luc Van Bortel, Brant Delafontaine

Pageof 1